|
|
 |
|
| |
|
|
|
|
 |
 |
|
Cell Genesys' extensive technology and patent estate is a reflection of the company's scientific strength and dedication to identifying and protecting discoveries that could someday result in novel therapies. The company currently has an extensive patent portfolio which includes approximately 358 issued or granted patents and over 319 pending patent applications in the areas of cancer immunotherapies, oncolytic virus therapies, and gene therapy technologies. |
|
|
